Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $2.204B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZYME | ZYMEWORKS INC | 22,970,388 | $605M | 27.4% | $9.83 | +121.8% | COM | 98985Y108 |
| ANAB | ANAPTYSBIO INC | 7,880,094 | $382M | 17.3% | $23.54 | +65.6% | COM | 032724106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,706,469 | $290M | 13.2% | $120.72 | +27.0% | SHS USD | G50871105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 4,288,120 | $200M | 9.1% | $32.41 | +37.4% | COM | 22663K107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 3,115,000 | $77.91M | 3.5% | $24.88 | — | SPONSORED ADS | 152309100 |
| CRSP | CRISPR THERAPEUTICS AG | 1,389,276 | $72.85M | 3.3% | $71.59 | -16.3% | NAMEN AKT | H17182108 |
| MBX | MBX BIOSCIENCES INC | 2,123,604 | $66.98M | 3.0% | $18.46 | +31.5% | COM | 55287L101 |
| IMNM | IMMUNOME INC | 2,855,590 | $61.34M | 2.8% | $8.38 | +109.5% | COM | 45257U108 |
| ORIC | ORIC PHARMACEUTICALS INC | 6,728,116 | $55.04M | 2.5% | $15.26 | -24.6% | COM | 68622P109 |
| GLPG | GALAPAGOS NV | 1,667,119 | $54.51M | 2.5% | $32.49 | — | SPON ADR | 36315X101 |
| XNCR | XENCOR INC | 3,251,112 | $49.77M | 2.3% | $32.11 | -53.5% | COM | 98401F105 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $35.35M | 1.6% | $11.58 | — | COM NEW | 107924102 |
| ETON | ETON PHARMACEUTICALS INC | 2,030,544 | $34.34M | 1.6% | $9.01 | +95.2% | COM | 29772L108 |
| CGON | CG ONCOLOGY INC | 772,000 | $32.05M | 1.5% | $41.38 | 0.0% | COM | 156944100 |
| ZBIO | ZENAS BIOPHARMA INC | 789,500 | $28.67M | 1.3% | $32.89 | 0.0% | COM | 98937L105 |
| NGNE | NEUROGENE INC | 1,271,342 | $26.19M | 1.2% | $14.32 | +73.8% | COM | 64135M105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 334,380 | $23.26M | 1.1% | $69.55 | — | SPONSORED ADS | 86366E106 |
| PCVX | VAXCYTE INC | 450,000 | $20.76M | 0.9% | $44.73 | 0.0% | COM | 92243G108 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,625,000 | $16.96M | 0.8% | $4.32 | +44.1% | COM | 03843E104 |
| VYGR | VOYAGER THERAPEUTICS INC | 4,002,847 | $15.73M | 0.7% | $3.88 | — | COM | 92915B106 |
| CGON | CG ONCOLOGY INC | 292,800 | $12.16M | 0.6% | $41.38 | 0.0% | Call | 156944100 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 573,183 | $10.37M | 0.5% | $13.39 | +11.5% | COM NEW | 046513206 |
| MNKD | MANNKIND CORP | 1,660,000 | $9.412M | 0.4% | $5.51 | 0.0% | COM NEW | 56400P706 |
| — | NUVATION BIO INC | 963,333 | $8.631M | 0.4% | $10.45 | — | *W EXP 02/10/202 | 67080N119 |
| EOLS | EVOLUS INC | 675,000 | $4.489M | 0.2% | $6.77 | 0.0% | COM | 30052C107 |
| IBIO | IBIO INC | 2,228,000 | $4.3M | 0.2% | $1.36 | 0.0% | COM NEW | 451033708 |
| MREO | MEREO BIOPHARMA GROUP PLC | 7,856,466 | $3.274M | 0.1% | $0.42 | — | SPON ADS | 589492107 |
| CAMP | CAMP4 THERAPEUTICS CORP | 325,000 | $1.992M | 0.1% | $4.25 | 0.0% | COM | 13463J101 |
| XNCR | XENCOR INC | 67,500 | $1.033M | 0.0% | $32.11 | -53.5% | Call | 98401F105 |
| SRZNW | SURROZEN INC | 4,444 | $100K | 0.0% | $7.07 | — | *W EXP 08/01/203 | 86889P117 |